(Q42256838)

19 October 2017

title

The multifaceted effect of PB1-F2 specific antibodies on influenza A virus infection (English)

1 reference

19 October 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

I Krejnusová

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Práznovská

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

G Russ

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

13 September 2013

1 reference

19 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24210094%20AND%20SRC:MED&resulttype=core&format=json

Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82.

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

CpG DNA as a vaccine adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Protective efficacy of a DNA influenza virus vaccine is markedly increased by the coadministration of a Schiff base-forming drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Differential localization and function of PB1-F2 derived from different strains of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

A novel influenza A virus mitochondrial protein that induces cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Pathogenicity of highly pathogenic avian influenza virus in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

A semi-empirical method for prediction of antigenic determinants on protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

PB1-F2 expedition from the whole protein through the domain to aa residue function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Antibodies to PB1-F2 protein are induced in response to influenza A virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Epitope-specific TCR repertoire diversity imparts no functional advantage on the CD8+ T cell response to cognate viral peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

The 2009 H1N1 pandemic influenza virus: what next?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Identification of novel influenza A virus proteins translated from PA mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Synthesis of full length PB1-F2 influenza A virus proteins from 'Spanish flu' and 'bird flu'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Epidemiologic parameters and evaluation of control measure for 2009 novel influenza a (H1N1) in Xiamen, Fujian Province, China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Systemic administration of CpG oligodeoxynucleotide and levamisole as adjuvants for gene-gun-delivered antitumor DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Preventing and treating influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

1918 Influenza: the mother of all pandemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Preparation of monoclonal antibodies for the diagnosis of influenza A infection using different immunization protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022

Prevalence of PB1-F2 of influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.08.022